DBV DBV Technologies SA

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

Information Regarding the Total Number of Voting Rights and 

Total Number of Shares of the Company as of February 28, 2026

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 



Date



 		Total number of shares Total number of voting rights
02/28/2026



 		278,352,082



 		 



Total gross of voting rights: 278,352,082



 
 



Total net* of voting rights: 278,236,200



 

* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment



EN
03/03/2026

Underlying

DBVDBV Technologies SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DBV Technologies SA

 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies intégrera les indices CAC Mid 60 et SBF 120 à l'issue...

DBV Technologies intégrera les indices CAC Mid 60 et SBF 120 à l'issue de la révision annuelle d'Euronext Paris Châtillon, France, le 24 mars (22 :30 CET) 2026 DBV Technologies intégrera les indices CAC Mid 60 et SBF 120 à l'issue de la révision annuelle d'Euronext Paris Les modifications sont entrées en vigueur le lundi 23 mars 2026, après la clôture des marchés financiers DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT – CUSIP : 23306J309) (la « Société »), société biopharmaceutique de stade avancé, a annoncé aujourd'hui qu'à la suite de la révision ...

13h / 39m 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euro...

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Châtillon, France, March 24, 2026 DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Changes went into effect on Monday, March 23, 2026 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, today announced that following the annual review of the Euronext Paris indices on March 12, 2026, the Scientific Council of the Indices has admitted DBV to the CAC Mid 60 and SBF 120 Indices. Th...

13h / 39m 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies to Participate in Upcoming March Investor Conferences

DBV Technologies to Participate in Upcoming March Investor Conferences Châtillon, France, March 4, 2026 DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a late-stage biopharmaceutical company, today announced the company will participate at the following investor conferences in March: Citizens Life Sciences Conference – March 10, 2026Format:              Fireside Chat Time:                 1:40pm ET Leerink Partners Global Healthcare Conference – March 11, 2026Format:              1 ...

March 4, 2026 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies annonce sa participation à plusieurs conférences inve...

DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars Châtillon, France, le 4 mars (22 :30 CET) 2026 DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT – CUSIP : 23306J309) (la « Société »), société biopharmaceutique de stade avancé, annonce aujourd’hui sa participation aux conférences investisseurs suivantes au mois de mars : Citizens Life Sciences Conference – 10 mars 2026Format:               Discussion « Fireside Chat »Heure:      ...

March 4, 2026 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information Regarding the Total Number of Voting Rights and Total Numb...

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345  Date  Total number of shares Total number of voting rights02/28/2026 278,352,082  Total gross of voting rights: 278,352,082  Total net* of voting rights: 278,236,200  * Net total = total number of voting rights at...

March 3, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch